The Joint Corp. (JYNT)
USD 10.5
(1.5%)
USD 10.5
(1.5%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 107.14 Million USD | 7.04% |
| 2022 | 92.08 Million USD | 26.7% |
| 2021 | 72.67 Million USD | 39.3% |
| 2020 | 52.17 Million USD | 21.66% |
| 2019 | 42.88 Million USD | 56.06% |
| 2018 | 27.47 Million USD | 25.75% |
| 2017 | 21.85 Million USD | 24.27% |
| 2016 | 17.58 Million USD | 59.63% |
| 2015 | 11.01 Million USD | 126.18% |
| 2014 | 4.87 Million USD | 23.24% |
| 2013 | 3.95 Million USD | 133.23% |
| 2012 | 1.69 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 25.91 Million USD | 1.2% |
| 2024 Q1 | 25.6 Million USD | -1.73% |
| 2023 FY | 98.56 Million USD | 7.04% |
| 2023 Q3 | 26.86 Million USD | 0.59% |
| 2023 Q4 | 26.05 Million USD | -3.04% |
| 2023 Q1 | 25.82 Million USD | 2.43% |
| 2023 Q2 | 26.71 Million USD | 3.43% |
| 2022 Q4 | 25.21 Million USD | 4.56% |
| 2022 Q1 | 20.12 Million USD | 0.51% |
| 2022 Q2 | 22.63 Million USD | 12.44% |
| 2022 Q3 | 24.11 Million USD | 6.55% |
| 2022 FY | 92.08 Million USD | 26.7% |
| 2021 Q1 | 15.78 Million USD | 4.54% |
| 2021 FY | 72.67 Million USD | 39.3% |
| 2021 Q2 | 18.18 Million USD | 15.19% |
| 2021 Q3 | 18.69 Million USD | 2.81% |
| 2021 Q4 | 20.02 Million USD | 7.13% |
| 2020 Q1 | 12.15 Million USD | -0.68% |
| 2020 Q2 | 11.22 Million USD | -7.7% |
| 2020 Q3 | 13.69 Million USD | 22.06% |
| 2020 FY | 52.17 Million USD | 21.66% |
| 2020 Q4 | 15.09 Million USD | 10.21% |
| 2019 Q4 | 12.24 Million USD | 8.33% |
| 2019 Q2 | 9.87 Million USD | 4.19% |
| 2019 Q1 | 9.47 Million USD | 20.37% |
| 2019 FY | 42.88 Million USD | 56.06% |
| 2019 Q3 | 11.29 Million USD | 14.47% |
| 2018 Q3 | 6.97 Million USD | 7.26% |
| 2018 FY | 27.47 Million USD | 25.75% |
| 2018 Q4 | 7.87 Million USD | 12.79% |
| 2018 Q2 | 6.5 Million USD | 6.2% |
| 2018 Q1 | 6.12 Million USD | 2.97% |
| 2017 Q1 | 4.93 Million USD | -1.91% |
| 2017 FY | 21.85 Million USD | 24.27% |
| 2017 Q4 | 5.94 Million USD | 3.88% |
| 2017 Q3 | 5.72 Million USD | 9.19% |
| 2017 Q2 | 5.24 Million USD | 6.34% |
| 2016 Q1 | 3.52 Million USD | 16.52% |
| 2016 FY | 17.58 Million USD | 59.63% |
| 2016 Q4 | 5.02 Million USD | 5.08% |
| 2016 Q3 | 4.78 Million USD | 12.68% |
| 2016 Q2 | 4.24 Million USD | 20.46% |
| 2015 Q1 | 1.96 Million USD | 32.65% |
| 2015 Q3 | 3.39 Million USD | 28.75% |
| 2015 Q2 | 2.63 Million USD | 34.25% |
| 2015 Q4 | 3.02 Million USD | -10.82% |
| 2015 FY | 11.01 Million USD | 126.18% |
| 2014 FY | 4.87 Million USD | 23.24% |
| 2014 Q1 | 982.31 Thousand USD | -13.81% |
| 2014 Q4 | 1.47 Million USD | 20.21% |
| 2014 Q2 | 1.17 Million USD | 19.88% |
| 2014 Q3 | 1.23 Million USD | 4.51% |
| 2013 Q3 | 986.02 Thousand USD | 0.0% |
| 2013 Q4 | 1.13 Million USD | 15.59% |
| 2013 FY | 3.95 Million USD | 133.23% |
| 2012 FY | 1.69 Million USD | 0.0% |
| 2001 Q3 | 19.08 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 682.6 Million USD | 84.303% |
| Addus HomeCare Corporation | 339.87 Million USD | 68.474% |
| AirSculpt Technologies, Inc. | 121.9 Million USD | 12.104% |
| Amedisys, Inc. | 457.07 Million USD | 76.558% |
| Astrana Health, Inc. | 214.95 Million USD | 50.153% |
| Aveanna Healthcare Holdings Inc. | 595.43 Million USD | 82.005% |
| IMAC Holdings, Inc. | 3.84 Million USD | -2684.111% |
| biote Corp. | 127.48 Million USD | 15.95% |
| Cryo-Cell International, Inc. | 22.9 Million USD | -367.875% |
| Cross Country Healthcare, Inc. | 432.06 Million USD | 75.2% |
| COMPASS Pathways plc | -242.93 Thousand USD | 44205.82% |
| DocGo Inc. | 178.95 Million USD | 40.123% |
| The Ensign Group, Inc. | 590.75 Million USD | 81.862% |
| Healthcare Services Group, Inc. | 251.45 Million USD | 57.387% |
| InnovAge Holding Corp. | 132.06 Million USD | 18.865% |
| LifeStance Health Group, Inc. | 302.09 Million USD | 64.531% |
| Mobile-health Network Solutions Class A Ordinary Shares | -1.07 Million USD | 10098.628% |
| ModivCare Inc. | 446.95 Million USD | 76.027% |
| NewGenIvf Group Limited | 1.68 Million USD | -6271.195% |
| Option Care Health, Inc. | 981.22 Million USD | 89.08% |
| P3 Health Partners Inc. | 31.63 Million USD | -238.706% |
| P3 Health Partners Inc. | 31.63 Million USD | -238.706% |
| The Pennant Group, Inc. | 61.9 Million USD | -73.085% |
| Surgery Partners, Inc. | 529.4 Million USD | 79.76% |
| Syra Health Corp. Class A Common Stock | 1.41 Million USD | -7489.05% |
| Talkspace, Inc. | 74.38 Million USD | -44.057% |
| Talkspace, Inc. | 74.38 Million USD | -44.057% |
| The Oncology Institute, Inc. | 59.57 Million USD | -79.863% |
| The Oncology Institute, Inc. | 59.57 Million USD | -79.863% |